PTP4A3 and breast carcinoma: In addition, previous studies have associated high PRL-3 expression with poor prognoses in node-positive TNBC and other subtypes including c-Erb-B overexpressing breast tumors [33, 50], but very little mechanistic evidence implicates a role for PRL-3 in driving breast cancer progression.